SCHEMBL3852844

SCHEMBL3852844

O=C(CCCC(=O)c1ccc(F)cc1)CCCC(=O)c1ccc(F)cc1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.88
RAB9A P51151 2/20 0.88
HTR7 P34969 1/20 0.69
PTPN1 P18031 1/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TSHR P16473 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KDM4E B2RXH2 1/20 0.51
HSD17B10 Q99714 1/20 0.51
CHRM2 P08172 1/20 0.50
HTR1A P08908 1/20 0.50
ADRA2A P08913 1/20 0.50
DRD1 P21728 1/20 0.50
ADRA1A P35348 1/20 0.50
OPRM1 P35372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14089801 0.91 NPC1 (0.72) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL9680520 0.89 NPC1 (0.91) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL3424496 0.87 NPC1 (0.87) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL9680984 0.87 NPC1 (0.87) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL1040636 0.87 NPC1 (0.87) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL296337 0.86 NPC1 (0.84) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL28197598 0.86 NPC1 (0.84) NPC1RAB9AHTR7MEN1KMT2A
SCHEMBL14605918 0.86 NPC1 (0.77) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL26584242 0.84 NPC1 (0.82) NPC1RAB9AHTR7PTPN1MEN1
SCHEMBL27983192 0.84 NPC1 (0.81) NPC1RAB9AHTR7PTPN1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885703-A4 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES MICROBIA INC (US) 2009-09-02 EP disclosed
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US disclosed
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US disclosed
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids MICROBIA, INC. (US) 2009-04-16 US disclosed
US-20080287663-A1 Process For Production Of 4-Biphenylyazetidin-2-Ones MICROBIA, INC. (US) 2008-11-20 US disclosed
US-20080287663-A1 Process For Production Of 4-Biphenylyazetidin-2-Ones MICROBIA, INC. (US) 2008-11-20 US disclosed
US-20080287663-A1 Process For Production Of 4-Biphenylyazetidin-2-Ones MICROBIA, INC. (US) 2008-11-20 US disclosed
US-20080200669-A1 Processes For Production of Phenolic 4-Biphenylylazetidin-2-Ones MICROBIA, INC. (US) 2008-08-21 US disclosed
EP-1896135-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS Microbia, Inc. (US) 2008-03-12 EP disclosed
EP-1893571-A2 PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES Microbia Inc. (US) 2008-03-05 EP disclosed
EP-1885703-A2 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES Microbia, Inc. (US) 2008-02-13 EP disclosed
WO-2006127893-A2 PROCESSES FOR PRODUCTION OF 4-(BIPHENYLYL)AZETIDIN-2-ONE PHOSPHONIC ACIDS MICROBIA, INC. (US) 2006-11-30 WO disclosed
WO-2006122020-A2 PROCESS FOR PRODUCTION OF 4-BIPHENYLYAZETIDIN-2-ONES MICROBIA, INC. (US) 2006-11-16 WO disclosed
WO-2006122216-A2 PROCESSES FOR PRODUCTION OF PHENOLIC 4-BIPHENYLYLAZETIDIN-2-ONES MICROBIA, INC. (US) 2006-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287663-A1 Process For Production Of 4-Biphenylyazetidin-2-Ones CYP4Z1, CYP4F12, CYP4F2 NPC1 1698/4885RAB9A 1251/4885HTR7 2620/4885
US-20080200669-A1 Processes For Production of Phenolic 4-Biphenylylazetidin-2-Ones CYP4B1, CYP4F2, CYP4F12 NPC1 1948/4885RAB9A 1841/4885HTR7 2167/4885
US-20090099355-A1 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids PIK3CA, PPA1, PIK3CB NPC1 3374/4885RAB9A 1175/4885HTR7 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.